Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Prayers for you and your son. I hope he makes a complete recovery.
The best post, on this board, in a very long while. Absolutely, spot on!
I didn't see his name called out. Speculation.
Please, can you supply a link to where it says that NP is under investigation?
Could Yo have let the cat partially out of the bag?
What if, Dr Yo was correct, and the goal is to destroy all value, and credibility in Cytodyn? Run the value to as low as they (shareholder's group) can get it. Take control of the company and merge with InCellDX, to restore credibility. Maybe the goal, all along, was to liquidate Cytodyn and get the intellectual property into InCellDX. Perhaps InCellDX will be the one taking over Cytodyn. Thus, the transfer of wealth is complete. Currently, that is the way the planets are aligning. Maybe we have underestimated our opponents. What a scary situation is brewing. The investigation doesn't have to prove any wrong doing. It just needs to cast shade, for this time frame.
Personally, I don't think we have months. There goal is to never let this get to a vote.
I tried asking Okapi partners some simple questions. The gentleman, that took my questions, was doubtful that they would answer. He was doubtful that they would answer questions at all. That was two weeks ago. I have received no correspondence. So much for more information.
Hey, aren't you familiar with some of their business skills?
Or even current success. IMHO
You are welcome to state your opinion.
Shareholders do not trust that the 13d group is not going to rob them blind. Their approach speaks volumes. That is my opinion.
To save time, yes.
Alex Keown (the author) owns Keown Media Services. This is another bought and paid for article.
http://www.alexkeown.com/
My mistake, I shouldn't have guessed. I have read it in other posts. I apologize for dragging you through the mud, with the others.
Even you, have said that the very first thing, would be a reverse split, to reorganize the finances. Of course, they would have to reissue a few million shares to take care of day to day business, run clinical trials, and do a little M&A (I threw in that part).
But, whatabout all those people talking about stuff in the past? When we're asking for transparency of how many shares, of InCellDX, they own so we can figure out what might happen in the future.
Did you see that 3X answered that Tony C had all of the experience and credentials, having put in years with Gilead? Tony C is not running for any position with the company.
Therefore, I will call that a non-existent answer.
That's what we are trying to sort out. Now, we find out that part of the group has been bragging about flipping CYDY shares and manipulating share pricing and PR for the last year. The more we see, of this group, the more toxic they seem. Certainly, at this point, they do not seem to be saviors of any kind. However, we are still vetting them out. We shall continue, to do so, until it is time to vote. Per your suggestion.
"Ken Squire is the founder and president of 13D Monitor, an institutional research service on shareholder activism, and the founder and portfolio manager of the 13D Activist Fund, a mutual fund that invests in a portfolio of activist 13D investments."
Anything 13d is this guy's angle. His little niche in life. No prejudice there! No sir, none at all. Yeah, right!
So, you listed one person, and I appreciate your candor. What were the circumstances regarding his departure from Cytodyn? By listing one person, are you suggesting that the other nominees won't bring as much necessary experience?
Please list the successfully completed clinical trials, and completed BLA's, for immunomodulator therapies, by the 13d nominees. We want to be clear about your confidence that they can do a better job.
Thank you for posting! I truly appreciate you helping us to better understand what, a work of art, this molecule truly is.
The more we see, the more toxic they look!
This is the second time you've asked. What's up?
Thank you for your response.
As each day goes by, your prior post is being illuminated. I still believe you are very correct about the 13d group.
"The 13D proxy action is to benefit new large investors who will buy shares in a secondary and will be allowed to short sell CYDY with a prior agreement to be allocated shares in the secondary offering possibly with warrants at a below market price. It happens very frequently in pre-revenue biotech and is legal to do. Easy pickings from retail, they will without a doubt legally rob current retail investors in this manner.
Your bear thesis opinions are water under the bridge at this point. The 13 D group poses a clear danger of current shareholders being legally robbed in a dilutive secondary stock offering."
Wow, you're really off the wall there. Sorry, to have offended your sensibilities. But, it does matter, since there is speculation of them either purchasing, or merging with InCellDX. It would help to clarify if they are in this to dilute the share value to shake out the majority of retail shareholders and allow them to become the majority shareholders (transfer the wealth). At that point they could sell the company off to a big pharmaceutical company, and increase their wealth even more. It would go a long way to dispelling the idea that this is not a shady attempt to rob everybody blind.
To be more accurate, some of their shares were purchased with their own money. However, that doesn't move the needle, for what was asked.
Very well put. You are exactly right! What does this group bring to the table, that isn't already in place? Don't say character. So far, they have not differentiated themselves from what is in place now. What do they bring that will help the business. Additionally, show some transparency. How many, of the group, are share holders in InCellDX?
"It doesn't really matter what all you people think."
And that's the rub. It doesn't matter know, and it will not matter later. Thanks, for pointing that out very succinctly! For me, you have hit the nail on the head. More exhibition of the malicious intent against the retail longs.
"We also took a charge of $2.9 million to write down our investment in InCellDX, Inc. to its fair value as of December 31, 2018."
According to OPKO Health, they reported their share of loss, as a share holders in InCellDX. I am not sure how large their holdings were. Apparently, 2018 was a bad year. This was found on their 2018 10K.
Pretty much sums up what we were all thinking. And, it makes us very happy.
Do you have to have an active license, in every state, for transactional purposes? Maybe, it is only necessary for litigations. I'm not an attorney. This seems to be a gray area.
I believe Holly only received her first dose. Her condition deteriorated in the time from when she stopped treatment, until she started with Leronlimab. She developed tumor(s) on her spine, which caused her excruciating pain. They took another couple of weeks to treat her pain, before continuing treatment. The cancer had spread throughout her body. Her deterioration was caused by lack of treatment. Even her husband acknowledged that.
AF contacted them and interfered with her treatment. He is less than human! He should have been prosecuted.
And yet, if you had a relative, who had this devastating death sentence disease, you would want this treatment for her. Sometimes, it's not all about the money.
Those are amazing results, for a "saline solution". Finally, there might be some hope for this horrible disease! This should get break through designation. What an amazing molecule we have!
Well put. Thank you for that.
This post should be pinned up top. Excellent post! Thank you for posting!
My point is, I can't believe you are touting a company that has been managed from 20.00, share price, to one dollar. Is that what we need? We know what we have. I am understanding that you think CYDY deserves bad management. I don't. I am not happy with what we have. However, I will not vote to bring in worse. The 13D team is working against the company now. They will do it worse, if they get control. How about touting some winners?
Correct again. They are playing their games at our expense. That makes them no better than what we currently have. It foretells what they will be like if they are handed the reigns to the company. It is malicious intent.